AtriCure had its Relative Strength (RS) Rating upgraded from 77 to 86 Wednesday.
Hone Your Stock-Picking Skills By Focusing On These Factors
This proprietary rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
Over 100 years of market history reveals that the best-performing stocks typically have an RS Rating north of 80 as they launch their biggest price moves.
AtriCure is building a consolidation with a 43.11 entry. See if the stock can clear the breakout price in volume at least 40% higher than normal.
The company posted 0% earnings growth in the latest quarterly report. Sales increased 14%.
The company earns the No. 10 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, Brainsway ADR and iRadimed are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
